---
schema_version: "secwatch.filing_event.v1"
accession: "0000105770-22-000014"
form_type: "8-K"
ticker: "WST"
cik: "0000105770"
company_name: "WEST PHARMACEUTICAL SERVICES INC"
filed_at: "2022-04-28T23:59:59+00:00"
generated_at: "2026-06-26T03:03:55.310221+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# West Pharma Q1 net sales $720M (+7.4%), adj. EPS $2.30; raises FY2022 adj. EPS guidance

## Summary
- Net sales $720.0M (+7.4% YoY); organic sales growth 11.0%.
- Reported diluted EPS $2.29 (+15.1%), adjusted diluted EPS $2.30 (+12.2%).
- Raises FY2022 adjusted EPS guidance to $9.30-$9.45 from $9.20-$9.35; reaffirms net sales $3.05B-$3.075B.
- Q3 dividend $0.18/share, payable Aug 3, record Jul 20; repurchased 390k shares for $147.1M.
- Proprietary Products segment sales $601.3M (+10.6%); HVP organic growth double-digit.

## SEC filing metadata
- accession: 0000105770-22-000014
- form_type: 8-K
- ticker: WST
- cik: 0000105770
- company_name: WEST PHARMACEUTICAL SERVICES INC
- filed_at: 2022-04-28T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/105770/000010577022000014/0000105770-22-000014-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/105770/000010577022000014/wst-20220428.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000105770-22-000014
- JSON: https://secwatch.observer/filing/0000105770-22-000014.json
- Plain text: https://secwatch.observer/filing/0000105770-22-000014.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.